Literature DB >> 19593525

Cognitive function in breast cancer survivors.

Janette Vardy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19593525     DOI： 10.1007/978-0-387-75115-3_24

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  29 in total

1.  Impact of increasing physical activity on cognitive functioning in breast cancer survivors: Rationale and study design of Memory & Motion.

Authors:  Sheri J Hartman; Loki Natarajan; Barton W Palmer; Barbara Parker; Ruth E Patterson; Dorothy D Sears
Journal:  Contemp Clin Trials       Date:  2015-09-30       Impact factor: 2.226

2.  A randomized trial of cognitive rehabilitation in cancer survivors.

Authors:  M M Cherrier; K Anderson; D David; C S Higano; H Gray; A Church; S L Willis
Journal:  Life Sci       Date:  2013-09-05       Impact factor: 5.037

3.  Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors.

Authors:  Jennifer Bruno; S M Hadi Hosseini; Shelli Kesler
Journal:  Neurobiol Dis       Date:  2012-07-20       Impact factor: 5.996

4.  Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study.

Authors:  Sheri J Hartman; Sandahl H Nelson; Emily Myers; Loki Natarajan; Dorothy D Sears; Barton W Palmer; Lauren S Weiner; Barbara A Parker; Ruth E Patterson
Journal:  Cancer       Date:  2017-09-19       Impact factor: 6.860

5.  Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls.

Authors:  Shelli R Kesler; Jeffrey S Wefel; S M Hadi Hosseini; Maria Cheung; Christa L Watson; Fumiko Hoeft
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

6.  Prefrontal cortex and executive function impairments in primary breast cancer.

Authors:  Shelli R Kesler; Jamie S Kent; Ruth O'Hara
Journal:  Arch Neurol       Date:  2011-11

7.  Identifying cytokine predictors of cognitive functioning in breast cancer survivors up to 10 years post chemotherapy using machine learning.

Authors:  Ashley M Henneghan; Oxana Palesh; Michelle Harrison; Shelli R Kesler
Journal:  J Neuroimmunol       Date:  2018-04-19       Impact factor: 3.478

Review 8.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

9.  Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy.

Authors:  Shelli R Kesler; Christa Watson; Della Koovakkattu; Clement Lee; Ruth O'Hara; Misty L Mahaffey; Jeffrey S Wefel
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

Review 10.  Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review.

Authors:  Ashley Henneghan
Journal:  Support Care Cancer       Date:  2015-09-29       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.